What Tilray Thinks About The 'Farming Business' And Why The Company May Need To Raise More Capital Soon
Although many companies are starting to gear up to release financial results for the first quarter, investors have nevertheless waited patiently for Tilray ( TLRY ) to release its results for the fourth...
Where the Democratic Candidates Stand on Cannabis
Though marijuana legalization may not be the top overall campaign issue heading into 2020, it remains an important part of many candidates' platforms.
Cannabis Stocks ACB, CRON, APHA, TLRY Trending Lower Today
Cannabis Stocks ACB, CRON, APHA, TLRY Trending Lower TodayCannabis sector trending lower The overall cannabis sector took a hit today amid the broader market’s declines. The volatility index (VIX) jumped...
Tilray Is Still Too High
Earlier this week, Canadian cannabis firm Tilray ( TLRY ) reported its fourth quarter results . While the company beat analyst estimates on the top line, the bottom line saw a much larger than expected...
Vape Distributor Greenlane Holdings Files S-1 Form, Plans NASDAQ IPO
Florida-based Greenlane Holdings, a distributor of premium vaporization products and consumption accessories, said it applied to list its class A common stock on the NASDAQ Global Market under the ticker...
CRON, ACB, CGC, APHA, and Other Cannabis Stocks Trend Lower
CRON, ACB, CGC, APHA, and Other Cannabis Stocks Trend LowerCannabis sectorThe overall cannabis sector was trading almost flat to negative in the first half of March 21. The Horizons Marijuana Life Science...
Investing in Marijuana, Without Tilray
Down huge from its highs, Tilray is far from a steal, but there’s still plenty green to be made in this space.
Canopy Growth: What’s Its Strategy in the United States?
Canopy Growth Sets Its Eyes on the US Market(Continued from Prior Part)Hemp’s potential Previously in this series, we discuss some of the product research from ebbu—Canopy Growth’s (WEED) (CGC) US subsidiary....
Innovative Industrial Properties: Analysts’ View in March
March Update: Analysts’ Ratings for TLRY, IIPR, and SPRWF(Continued from Prior Part)Innovative Industrial PropertiesLast week, Innovative Industrial Properties (IIPR) reported its earnings. The company...
Canopy Growth Sets Its Eyes on the US Market
Canopy Growth Sets Its Eyes on the US MarketNew acquisitionOn March 20, Canopy Growth (WEED) (CGC) announced that it signed a multiyear extraction agreement with HollyWeed. The company is back in the news...
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was incorporated in 2018 and is headquartered in Nanaimo, Canada.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Tilray's experience is unmatched worldwide. Our team professionals on the ground in 7 countries serves thousands of patients around the globe. Our flagship cultivation facility is among the most advanced in the world.
Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extracts. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.
We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.
Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.